Operations pain

Why can't I see White Label Rx pricing before I commit?

You cannot see per-vial pricing on White Label Rx up front because its model is quote-driven: its public FAQ directs clinics to contact for a custom, volume-negotiated quote rather than publishing rates as of June 2026. That means a clinic cannot quote a cash-pay patient on semaglutide or tirzepatide until a sales conversation produces numbers — a delay that lands right in the consult.

Quote-only pricing is not dishonest, but it is slow when you are trying to close a patient on the spot. Here is the symptom, the cause, and how visible pass-through pricing changes the workflow.

Quote-driven pricing No public per-vial rates Sales call before numbers Delay lands in the consult Visible cost on Fizy Health

The symptom: you can't quote the patient in the room

The pricing transparency problem shows up at the worst moment: a patient is in front of you ready to start semaglutide or tirzepatide, and you cannot tell them the cost because your platform does not show landed per-vial pricing. You either guess, quote a padded number to be safe, or tell the patient you will follow up — and follow-ups are where conversions go to die.

For owners, the same opacity makes margin planning a moving target. If the cost per vial is only knowable after a quote and can shift with volume tiers, building a predictable cash-pay program means working from estimates rather than numbers. The delay is not just minutes; it is the inability to make confident pricing decisions.

The cause: pricing lives in a sales process, not the catalog

White Label Rx advertises volume-negotiated rates with no middleman markup, but its public FAQ directs clinics to request a custom quote instead of listing per-vial prices as of June 2026. That is a deliberate model: rates are set through negotiation, so they live in a sales conversation rather than on the catalog page. It can yield good pricing at volume, but the trade-off is that you do not see a number until you ask for one.

When you evaluate this model, the right questions are about timing and visibility: how long from inquiry to a usable quote, whether per-vial rates appear in the ordering tool afterward, and how rates change as your volume moves between tiers. If pricing never surfaces inside the catalog and cart, the quote delay repeats every time a new SKU or tier comes up.

The fix: put resolved per-vial cost where you order

The delay disappears when pricing is visible at the point of decision. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment, so a clinician can quote a patient in the room and an owner can model margin from real numbers. There is no sales gate between you and the cost of the medication you are about to order.

Pass-through pricing is the structural difference: instead of a negotiated rate hidden in a quote, you see the 503A cost and the disclosed fee. The evaluation test is whether you can answer what does this vial cost without sending an email. When the catalog answers that question, the consult keeps moving and pricing stops being a bottleneck.

Negotiated quote — or visible cost before you order?

White Label Rx fits if

White Label Rx

A negotiated quote works for how you plan pricing.

  • You are comfortable contacting sales for a custom quote before you see per-vial rates.
  • Your patient quoting does not depend on seeing landed cost during the consult.
  • Volume-negotiated rates matter more to you than seeing numbers in the catalog.
Consider Fizy Health if

Fizy Health

You need per-vial cost visible before you quote anyone.

  • You quote cash-pay patients on GLP-1s and need landed per-vial cost in the moment.
  • You want to model margin from real numbers, not estimates pending a quote.
  • You want cost visible on each catalog and cart line, with the fee disclosed at payment.
FAQ

What clinics ask about White Label Rx pricing transparency.

  • Pricing

    Does White Label Rx show pricing up front?

    White Label Rx does not publish per-vial pricing on its public site as of June 2026; its FAQ directs clinics to contact for a custom, volume-negotiated quote. You see rates after a sales conversation rather than in the catalog.

  • Cause

    Why is White Label Rx pricing quote-driven?

    White Label Rx markets volume-negotiated rates with no middleman markup, so prices are set through negotiation and live in a sales process rather than on a public price list. The trade-off is that you do not see a number until you ask.

  • Impact

    How does the quote delay affect a clinic?

    Without visible per-vial cost, a clinician cannot quote a cash-pay patient during the consult and an owner cannot model margin from real numbers. That delay can stall conversions and make pricing decisions guesswork.

  • Evaluation

    What should I ask White Label Rx about pricing transparency?

    Ask how long from inquiry to a usable quote, whether per-vial rates appear in the ordering tool afterward, and how rates change as your volume moves between tiers. Confirm whether pricing ever surfaces in the catalog and cart.

  • Comparison

    How does Fizy Health handle pricing transparency?

    Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment. You can quote a patient in the room without a sales call.

  • Model

    What is pass-through pricing?

    Pass-through pricing shows the 503A pharmacy cost of the medication plus a disclosed facilitation fee, rather than a negotiated rate hidden in a quote. It lets clinics see landed cost before they order.

Sources reviewed June 2026

  • White Label Rx public website and FAQ (whitelblrx.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Quote the patient before they leave the room.

Fizy Health shows landed per-vial cost in catalog and cart before checkout, so pricing stops being a sales gate. Free to start.